Literature DB >> 8428791

International variations in the incidence of childhood bone tumours.

D M Parkin1, C A Stiller, J Nectoux.   

Abstract

Bone cancers comprise about 5% of childhood neoplasms. Osteosarcoma, the most common sub-type, shows a somewhat irregular geographic pattern of incidence, with low rates in some Asian (Indian, Japanese, Chinese) and Latin American populations. Incidence is similar in the sexes and rises steeply with age, accompanied by an increasing proportion of tumours localized in the long bones of the legs. Rates in the USA are higher in blacks than in whites, as a result of a higher incidence at ages 10 to 14 and of tumours of the leg bones. The descriptive epidemiology is consistent with early observations linking risk to the amount of bone growth. Ewing's sarcoma is rare in black populations (USA and Africa) and in eastern Asia. Compared with osteosarcoma, a lower percentage of tumours is localized to the long bones, and incidence rises less steeply with age and is accompanied by an increasing proportion of pelvic tumours. Chondrosarcoma is a rare cancer in children (less than 5% of bone cancers), with an age distribution similar to that of osteosarcoma and a sub-site distribution resembling that of Ewing's sarcoma. Little is known of the aetiology of these tumours; there is clearly a strong genetic predisposition in Ewing's sarcoma but, although the proportion of osteosarcoma cases of genetic origin seems to be small, environmental determinants so far suspected can account for only a small fraction of the total cases.

Entities:  

Mesh:

Year:  1993        PMID: 8428791     DOI: 10.1002/ijc.2910530305

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  28 in total

1.  Malignant bone tumors in Kuwait: a 10-year clinicopathological study.

Authors:  K C Katchy; F Ziad; S Alexander; H Gad; M Abdel Mota'al
Journal:  Int Orthop       Date:  2005-09-29       Impact factor: 3.075

2.  Incidence of multiple primary malignancies among patients with bone cancers in Sweden.

Authors:  Jianguang Ji; Kari Hemminki
Journal:  J Cancer Res Clin Oncol       Date:  2006-05-17       Impact factor: 4.553

Review 3.  Evolving management of colorectal cancer.

Authors:  Jochem van der Voort van Zijp; Harald J Hoekstra; Marc D Basson
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

4.  Follow-up of treated osteosarcoma patient.

Authors:  Gisele Eiras Martins; Stela Verzinhasse Perez
Journal:  Acta Ortop Bras       Date:  2012       Impact factor: 0.513

5.  Breed-specific incidence rates of canine primary bone tumors--a population based survey of dogs in Norway.

Authors:  Kristin P Anfinsen; Tom Grotmol; Oyvind S Bruland; Thora J Jonasdottir
Journal:  Can J Vet Res       Date:  2011-07       Impact factor: 1.310

Review 6.  Cancer of childhood in sub-Saharan Africa.

Authors:  Cristina Stefan; Freddie Bray; Jacques Ferlay; Biying Liu; D Maxwell Parkin
Journal:  Ecancermedicalscience       Date:  2017-07-28

7.  Outcome of multimodality treatment of Ewing's sarcoma of the extremities.

Authors:  Akshay Tiwari; Himesh Gupta; Sandeep Jain; Gauri Kapoor
Journal:  Indian J Orthop       Date:  2010-10       Impact factor: 1.251

Review 8.  3D tissue-engineered model of Ewing's sarcoma.

Authors:  Salah-Eddine Lamhamedi-Cherradi; Marco Santoro; Vandhana Ramammoorthy; Brian A Menegaz; Geoffrey Bartholomeusz; Lakesla R Iles; Hesham M Amin; J Andrew Livingston; Antonios G Mikos; Joseph A Ludwig
Journal:  Adv Drug Deliv Rev       Date:  2014-08-07       Impact factor: 15.470

9.  Descriptive epidemiology of childhood cancer in Cali: Colombia 1977-2011.

Authors:  Luis Eduardo Bravo; Luz Stella García; Paola Collazos; Paula Aristizabal; Oscar Ramirez
Journal:  Colomb Med (Cali)       Date:  2013-09-30

10.  Ewing's sarcoma of the ilium mimicking inflammatory arthritis of the hip: a case report.

Authors:  Manzoor Ahmed Halwai; Bashir Ahmed Mir; Mubashir Maqbool Wani; Arshad Bashir; Anwar Hussain
Journal:  Cases J       Date:  2009-06-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.